Clinical trialNCT04354155CompletedPhase 2Interventional

COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial

SponsorJohns Hopkins All Children's HospitalEnrollment40COVID-19Infection ViralThromboses, Venous

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety, dose-requirements, and exploratory efficacy of twice-daily subcutaneous enoxaparin as venous thromboembolism prophylaxis in children (birth to 18 years) hospitalized with signs and/or symptoms of SARS-CoV-2 infection (i.e., COVID-19).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Anthony Sochet, MD
Johns Hopkins All Children's Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Children'S of Alabama
Birmingham, Alabama, United States
Children'S Hospital Los Angeles
Los Angeles, California, United States
Hemostasis and Thrombosis Center Uc Davis
Sacramento, California, United States
Rady Children'S Hospital
San Diego, California, United States
Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
Children'S Hospital of Atlanta
Atlanta, Georgia, United States
Lurie Children'S Hospital
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Children'S Hospital New Orleans
New Orleans, Louisiana, United States
Johns Hopkins Hospital and Children'S Center
Baltimore, Maryland, United States
Boston Children'S Hospital
Boston, Massachusetts, United States
Children'S Hospital of Michigan
Detroit, Michigan, United States
Cohen Children'S Medical Center
New Hyde Park, New York, United States
Akron Children'S Hospital
Akron, Ohio, United States
Children'S Hospital Pittsburgh
Pittsburgh, Pennsylvania, United States
Children'S Medical Center of Dallas
Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Enoxaparin Prefilled Syringe [Lovenox]

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Jun 2020
Primary completion: 4 Jun 2021
Completion: 4 Jun 2021
Last update posted: 12 Oct 2022
Registered enrollment: 40
Registry id: NCT04354155

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.